Cutaneous T-cell lymphoma (CTCL) constitutes a malignant proliferation of T-lymphocytes that initially involves the skin, but later progresses to involve lymph nodes, blood, and other visceral organs. Diagnosis of early cutaneous disease as well as occult extra-cutaneous involvement remains difficult due to the limitations of sensitivity and specificity of current diagnostic techniques. Recently the investigators have succeeded in molecularly diagnosing CTCL by cloning the T-cell antigen receptor beta chain (TCR-B) gene rearrangement from malignant T-cells and generating patient-specific oligonucleotide probes which are capable of detecting this disease through polymerase chain reaction (PCR) amplification. The investigators intend to utilize this technique to: (1) Detect the presence of minimal residual disease; (2) demonstrate the earliest presence of the malignant clone in the skin; (3) determine the earliest onset of systemic (extracutaneous) involvement. They anticipate that the results of these experiments will elucidate the natural history of CTCL in individual patients, contribute to an understanding of the origin and progression of CTCL, and provide new probes for molecular diagnosis, therapeutic monitoring, and in-situ hybridization. Furthermore, they expect that the ability to clone TCR-B gene rearrangements rapidly will lay the foundation for new therapeutic approaches aimed at the immunomodulation of pathogenic T-cell clones in human T-cell malignancies.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
First Independent Research Support & Transition (FIRST) Awards (R29)
Project #
5R29CA055017-04
Application #
2096253
Study Section
General Medicine A Subcommittee 2 (GMA)
Project Start
1991-09-01
Project End
1996-08-31
Budget Start
1994-09-01
Budget End
1995-08-31
Support Year
4
Fiscal Year
1994
Total Cost
Indirect Cost
Name
University of Pennsylvania
Department
Dermatology
Type
Schools of Medicine
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Li, G; Chooback, L; Wolfe, J T et al. (1998) Overexpression of p53 protein in cutaneous T cell lymphoma: relationship to large cell transformation and disease progression. J Invest Dermatol 110:767-70
Li, G; Salhany, K E; Rook, A H et al. (1997) The pathogenesis of large cell transformation in cutaneous T-cell lymphoma is not associated with t(2;5)(p23;q35) chromosomal translocation. J Cutan Pathol 24:403-8
Gilliam, A C; Lessin, S R; Wilson, D M et al. (1997) Folliculotropic mycosis fungoides with large-cell transformation presenting as dissecting cellulitis of the scalp. J Cutan Pathol 24:169-75
Finn, D T; Jaworsky, C; Chooback, L et al. (1996) Correlation between clonotypic T-cell receptor beta chain variable region (TCR-V beta) gene expression and aberrant T-cell antigen expression in cutaneous T-cell lymphoma. J Cutan Pathol 23:306-11
Dietz, S B; Whitaker-Menezes, D; Lessin, S R (1996) The role of alpha E beta 7 integrin (CD103) and E-cadherin in epidermotropism in cutaneous T-cell lymphoma. J Cutan Pathol 23:312-8
Wasik, M A; Vonderheid, E C; Bigler, R D et al. (1996) Increased serum concentration of the soluble interleukin-2 receptor in cutaneous T-cell lymphoma. Clinical and prognostic implications. Arch Dermatol 132:42-7
Rook, A H; Kubin, M; Fox, F E et al. (1996) The potential therapeutic role of interleukin-12 in cutaneous T-cell lymphoma. Ann N Y Acad Sci 795:310-8
Li, G; Vowels, B R; Benoit, B M et al. (1996) Failure to detect human T-lymphotropic virus type-I proviral DNA in cell lines and tissues from patients with cutaneous T-cell lymphoma. J Invest Dermatol 107:308-13
Weinberg, J M; Jaworsky, C; Benoit, B M et al. (1995) The clonal nature of circulating Sezary cells. Blood 86:4257-62
Resnik, K S; Kantor, G R; Lessin, S R et al. (1995) Mycosis fungoides palmaris et plantaris. Arch Dermatol 131:1052-6

Showing the most recent 10 out of 18 publications